Literature DB >> 8105411

Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo.

E Toth1, E S Vizi, A Lajtha.   

Abstract

The local effect of nicotine on the extracellular levels of amino acids was examined in the striatum and frontal cortex of rats using microdialysis in vivo. The perfusion of 1 mM nicotine in Ringer's solution increased the extracellular levels of aspartic and glutamic acids by 40-50% in the striatum and had no effect on the levels of serine, glycine, glutamine, taurine or threonine. This effect of nicotine was dose- and Ca-dependent. At a 5 mM concentration, nicotine produced a more than 200% increase in the levels of aspartate, glutamate and taurine in the striatum; levels of glycine and threonine were also increased. Nicotine also increased the levels of these amino acids in the microdialysate from the frontal cortex. The effect of nicotine, tested in the striatum, was not influenced by mecamylamine or tetraethyl-ammonium chloride or haloperidol, but it was blocked by atropine. This indicated that muscarinic, cholinergic receptors participated in this effect of nicotine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105411     DOI: 10.1016/0028-3908(93)90192-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  25 in total

1.  Brain metabolic effects of acute nicotine.

Authors:  J W Pettegrew; K Panchalingam; R J McClure; J Levine
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

Review 2.  Drugs of abuse and immediate-early genes in the forebrain.

Authors:  R E Harlan; M M Garcia
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

3.  Complex Control of Striatal Neurotransmission by Nicotinic Acetylcholine Receptors via Excitatory Inputs onto Medium Spiny Neurons.

Authors:  Valentina Licheri; Oona Lagström; Amir Lotfi; Mary H Patton; Holger Wigström; Brian Mathur; Louise Adermark
Journal:  J Neurosci       Date:  2018-06-25       Impact factor: 6.167

4.  Effect of nicotine on the level of extracellular amino acids in the hippocampus of rat.

Authors:  E Toth
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

5.  Characterisation of extracellular amino acids in striatum of freely moving rats by in vivo microdialysis.

Authors:  J Semba; S Kito; M Toru
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.

Authors:  Alexander R Kosowski; Gvido Cebers; Aleta Cebere; Ann-Charlott Swanhagen; Sture Liljequist
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

7.  Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats.

Authors:  José A Larrauri; Dennis A Burke; Brandon J Hall; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2015-04-28       Impact factor: 4.530

8.  The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes.

Authors:  S Rossi; S Singer; E Shearman; H Sershen; A Lajtha
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

9.  Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors.

Authors:  Katsuya Suemaru; Kayo Yasuda; Kenta Umeda; Hiroaki Araki; Kazuhiko Shibata; Tominari Choshi; Satoshi Hibino; Yutaka Gomita
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

10.  A microdialysis study of glycinamide, glycine and other amino acid neurotransmitters in rat frontal cortex and hippocampus after the administration of milacemide, a glycine pro-drug.

Authors:  M H Doheny; S Nagaki; P N Patsalos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.